A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety and efficacy of an investigational
drug, V3381, for the treatment of diabetic peripheral neuropathic (DPN) pain (pain in one's
feet and legs, or even in one's hands and arms, sometimes experienced by people with
diabetes). An investigational drug is one that is not approved by the United States Food and
Drug Administration (FDA) and/or Health Canada.